Chapter 28 Patient Assessment Flashcards

1
Q

PPCP

A

Pharmacists’ Patient Care Process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

developed by the Joint Commission of Pharmacy Practitioners alongside other
major pharmacy organizations and key stakeholders.

A

Pharmacists’ Patient Care Process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

five elements that should be incorporated by pharmacists practicing patient-centered
care:

A
Collect
Assess
Plan
Implement
Follow-up:Monitor/Evaluate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

reason for the

patient’s visit.

A

Chief complaint (CC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

the onset of the

illness and modifying factors.

A

History of present illness (HPI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

all medications taken by any route

A

Medications, allergies, and immunizations:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

patient’s family medical

history,

A

Family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

patient’s social activities

that may relate to the presented illness

A

Social history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
This information is usually arranged by
organ system (i.e. gastrointestinal, respiratory, musculoskeletal)
A

ROS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Problem-Focused Interview

A

open-ended questions
and statements.
this method allows the patient to elaborate on his or her
condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Seven basic screening questions

may be used in the interview

A
LAST QSM
Location
Quality
Severity
Timing
Setting
Modifying factors
Associated symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where is the symptom?

A

Location:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is it like? Describe it.

A

Quality:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How bad is it? How does it interfere with your life?

A

Severity:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How long has it been present? When did it start? How often does it occur?

A

Timing:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How did it happen? What were you doing when it started?

A

Setting:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What makes it better or worse? What did you use to

treat it?

A

Modifying factors:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What other things have you noticed?

A

Associated symptoms:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

four identifiable sections that interview information should be organized to:

A

SOAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

all the information

reported by the patient as presented.

A

Subjective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

health care provider’s
physical or mental observations,
Medications may be listed here
if not reported by the patient.

A

Objective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

health care provider’s evaluation

and diagnosis of the case presented

A

Assessment:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

the health care provider’s treatment plan
and recommendations, the medication prescribed or discontinued, and
the patient counseling performed. It should include follow-up visits and
monitoring recommendations for the patient.

A

PLAN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Follow-up visits should include an

A

interim interview

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

4 main issues in an interim interview

A

control
adherence
complications
symptoms range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

general observation of the patient

A

Inspection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

use of the of touch for evaluation-brevity

A

palpation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

skin surfaces

A

light touch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

organs or masses

A

deeper touch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

fine, tactile sensation

A

fingertips

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

temperature

A

dorsal surface of the hand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Vibrations

A

palm surface at the metacarpal joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

deep palpation, including the palpation

of organs.

A

finger pads

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

assessing strength

A

two fingers or whole hand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

used to produce sounds, elicit tenderness, or assess reflexes in a patient.
locating organ borders, identifying organ shape
and position, and determining whether an organ is solid or filled with gas.
direct or indirectly

A

Percussion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

tapping a finger against the middle finger

A

Indirect percussion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

striking a fist

A

blunt percussion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

tympanic-drum sound

A

gas bubble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

hyperresonant/boom-like

A

emphysematous lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

resonant/hollow

A

healthy lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

thud-like sound

A

liver

42
Q

flat/very dull sound

A

normal muscle tissue

43
Q

Stethoscope

carried out last

A

Auscultation

44
Q

measures various physiological functions

should be included in every patient case presentation

A

Vital signs

45
Q

Vital signs

A
Weight
RR
Pulse
Temp
BP
46
Q

Adults: 12–20

newborns: 30–60
children: 20–40

A

Respiratory rate

47
Q

absence of breathing

A

Apnea

48
Q

difficult breathing or

shortness of breath

A

Dyspnea

49
Q

difficulty breathing in

supine position

A

Orthopnea

50
Q

deep, rapid breathing;

hyperventilation

A

hyperpnea

51
Q

deep, regular breathing with rate slow, normal, or
fast
Severe metabolic acidosis

A

Kussmaul breathing

Severe Metabolic AUSSidosis

52
Q

unpredictably irregular breathing

A

Ataxic respiration

53
Q

cyclic pattern of apnea and varied breathing

dying process

A

Cheyne-Stokes respiration

54
Q

Normal body temp

A

37 C /98.6 F

55
Q

rectal

A

1 F higher

56
Q

axillary

A

1 F lower

57
Q

normal pulse

A

60-100

58
Q

pulse generally is taken _______

A

at the radial artery

59
Q

normal BP

A

<120/80mmHg

60
Q

135-145 mEq/L

A

Normal Sodium

Na i3s-iqs

61
Q

3.5-5 mEq/L

A

K

K-3.s-s

62
Q

95-106 mEq/L

A

Cl

CIgs-loG

63
Q

8.2-10.8 mg/dL

A

Ca

CaB.z-lo.B

64
Q

2.6-4.5 mg/dL

A

P (phosphate)

65
Q

8-20 mg/dL

A

BUN-B-ZO

66
Q

cause false

high Na level.

A

Hypertriglyceridemia and hyperglycemia

67
Q

low K can be caused by

A

LOW Key ihi amp

diuretics and ampho B

68
Q

can cause a false increase in K

A

hemolysis

Hi! moLIEsis? K

69
Q

meds that can increase K

A
potaTESAHAT
TRIamterine
EPLErenone
SPIROnolactone
AmiloRIDE
HEParin
ACEi
TRImethoprim
70
Q

Chloride loss thru prox tubule in kidney can cause

A

Metab al(Ch)alLOSSis

71
Q

can cause decrease Mg

A

to lose Mg
Vomitting/diarrhea
Mgsuka/Mg-tae-tae

72
Q

1.5-2.2 mEq/L

A

Mg

i.s-Z.Z

73
Q

increased Mg levels

A

increase MgHAR
Hemolysis
Antacids
Renal insuff

74
Q

_____ inCreases Ca protein binding

A

Alkalosis

Sa Alcala madaming naka-bind

75
Q

_____Decreases Ca protein binding

A

Acidosis
Achi(Decrease)osis
Ac(High free calcium)

76
Q

Abnormal phosphate is associated with

A

MaDR PO4(police)
Malnutrition
Diarrhea
Refeeding syndrome

77
Q

Medications that can increase BUN

A

Tetracycline
Corticosteroids
high BUN in the CT steroid cycle

78
Q

false elevation of BUN

A

Chloral hydrate
false high BUN sa corals~
pretending mataas nasa corals naman

79
Q

false decrease in BUN

A

chloramphenicol
Streptomycin

Strip/colored Ramp false low BUN
kala mo low~mayaman pala

80
Q

Normal SCr

A

0.7-1.5

SCr0.T-I.S

81
Q

directly related to muscle mass and muscle

metabolism.

A

SCr

82
Q

Scr is high with these meds

A
SCaredy-
CATS ATA
Cimetidine
Amiloride
Triamterine
Spironolactone

ACEi
Trimethoprin
Aminogly-high dose

83
Q

Blood Glucose

A

Fasting <100
if >=126~diagnosis for diabetes
dyabet1ZG

84
Q

Total cholesterol

A

less than 200

85
Q

LDL

A

less than 100

86
Q

HDL

A

MEN:
greater than or equal to 40
WOMEN:
greater than or equal to 50

87
Q

A1c

A

<5.7

HbA1c Less than a S.T(Saint)

88
Q

INR

A

<1

2-3 on warfarin

89
Q

causes of High INR

A
High levels ThroPro-EC TOF-azole T-three
EryTHROmycin
CiPROfloxacin 
THREEmethoprim,
OmeprAZOLE
FluconAZOLE
90
Q

Low INR causes

A
LOW INNER~
Tyred Barbi Cyclo Rif Vit K
Cholestyramine
Barbiturates
Cyclosporine
Rifampin
Vit K
91
Q

AST

A

8-42
AYT saTWO
8 42

patabaan nalang ng utak

92
Q

ALT

A

3-30

ALT3-30

93
Q

LD

A

100-225

Loo-zzs

94
Q

False high liver transaminase

A

false liver enzyme”Riso”
or ISO my FAM so nagkaroon ako ng false hopes for my liver??WHAT??!
Isoniazid
Rifampin

95
Q

important information
about the current status of the kidneys
electrolytes and acid–base balance

A

Basic metabolic panel (BMP)

96
Q

BMP

A

Na Cl BUN Glucose
K CO SCr
135-145 95-105 8-20 <100~126
3-3.5 ? 0.7-1.5

97
Q

disorders
such as infection and anemia. Laboratory values measured include
hematocrit (Hct), hemoglobin (Hgb), red blood count (RBC), white blood
cell (WBC) count

A

CBC w or w/o diff

98
Q

risk for

atherosclerotic cardiovascular disease

A

Lipid panel:

99
Q

tests various activities of the liver,

synthetic function, and hepatic disease

A

Liver function:

100
Q

interference is caused by the pharmacological or the toxicological
drug effect

A

In vivo